Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · Real-Time Price · USD
3.010
+0.080 (2.73%)
Mar 31, 2025, 1:23 PM EDT - Market open
Atea Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Atea Pharmaceuticals stock has a target of 6.88, which predicts an increase of 128.57% from the current stock price of 3.01.
Analyst Consensus: Hold
* Price targets were last updated on Aug 13, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for Atea Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 1 | 1 | 1 | 1 | 1 | 1 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Morgan Stanley | Morgan Stanley | Sell → Hold Upgrades $2 → $6.88 | Sell → Hold | Upgrades | $2 → $6.88 | +128.57% | Aug 13, 2024 |
JP Morgan | JP Morgan | Hold → Sell Downgrades n/a | Hold → Sell | Downgrades | n/a | n/a | Aug 10, 2023 |
JP Morgan | JP Morgan | Hold Maintains $12 → $8 | Hold | Maintains | $12 → $8 | +165.78% | Mar 16, 2023 |
SVB Leerink | SVB Leerink | Hold Maintains $8 → $6 | Hold | Maintains | $8 → $6 | +99.34% | Jan 27, 2023 |
Morgan Stanley | Morgan Stanley | Sell Maintains $7 → $4 | Sell | Maintains | $7 → $4 | +32.89% | Jan 24, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
305.41M
EPS This Year
-1.73
from -2.00
EPS Next Year
-1.72
from -1.73
Revenue Forecast
Revenue | 2025 | 2026 |
---|---|---|
High | n/a | 925.3M |
Avg | n/a | 305.4M |
Low | n/a | n/a |
Revenue Growth
Revenue Growth | 2025 | 2026 |
---|---|---|
High | - | - |
Avg | - | - |
Low | - | - |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -1.72 | -1.67 | -1.28 |
Avg | -1.73 | -1.72 | -1.44 |
Low | -1.72 | -1.74 | -1.57 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.